Skip to main content
TipRanks
Go Ultimate75% OFF

IQ-AI (5Y1) AI Stock Analysis

0 Followers
DE:5Y1

IQ-AI

(Frankfurt:5Y1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue GrowthSteady revenue expansion indicates that IQ-AI has continued to increase commercial activity over several years rather than relying solely on a temporary uplift. A larger revenue base can improve operating leverage and provide a foundation for future earnings improvement if cost control strengthens.
Negative Factors
Persistent Net LossesThe company has not yet demonstrated sustainable earnings despite revenue growth and strong gross margins. A net loss equal to roughly 51% of revenue indicates that operating expenses remain too high relative to gross profit, limiting reinvestment capacity and increasing dependence on future financial improvement.

IQ-AI (5Y1) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap
EUR 1.79M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-7.3
Beta (1Y)
0.42
Revenue Growth
12.02%
EPS Growth
-57.14%
Country
Germany
Employees
7
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

IQ-AI Business Overview & Revenue Model

Company Description

Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and...

IQ-AI Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:5Y1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:IXIGB:IXI55NeutralGBP 27.92M-6.50-16.18%―13.04%15.88%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:GDRGB:GDR49NeutralGBP 14.45M-0.82-1044.57%―65.60%74.84%
GB:RENXGB:RENX44NeutralGBP 36.20M-3.36675.00%―――
GB:COGGB:COG41NeutralGBP 15.65M-9.63-54.17%―11.86%23.81%
GB:OBDGB:OBD40UnderperformGBP 15.46M-0.29-451.74%―33.37%86.41%

* Healthcare Sector Average

Performance Comparison

-50%0%50%GB:COGGB:GDRGB:IXIGB:OBDGB:RENXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:5Y1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:5Y1IQ-AI Limited―――
GB:COGCambridge Cognition Holdings29.00-4.00-12.12%
GB:GDRGenedrive plc0.900.1113.92%
GB:IXIIXICO plc12.751.5013.33%
GB:OBDOxford BioDynamics0.12-0.17-58.93%
GB:RENXRenalytix Plc OTC5.40-1.85-25.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.